Teva Pharmaceutical Industries Stock Price Prediction

TEVJF Stock  USD 17.80  0.00  0.00%   
As of 7th of October 2024, the relative strength index (RSI) of Teva Pharmaceutical's share price is approaching 46. This usually implies that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Teva Pharmaceutical, making its price go up or down.

Oversold Vs Overbought

46

 
Oversold
 
Overbought
The successful prediction of Teva Pharmaceutical's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Teva Pharmaceutical and does not consider all of the tangible or intangible factors available from Teva Pharmaceutical's fundamental data. We analyze noise-free headlines and recent hype associated with Teva Pharmaceutical Industries, which may create opportunities for some arbitrage if properly timed.
Using Teva Pharmaceutical hype-based prediction, you can estimate the value of Teva Pharmaceutical Industries from the perspective of Teva Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Teva Pharmaceutical to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Teva because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Teva Pharmaceutical after-hype prediction price

    
  USD 17.8  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Teva Pharmaceutical Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Teva Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
10.5114.6518.79
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Teva Pharmaceutical. Your research has to be compared to or analyzed against Teva Pharmaceutical's peers to derive any actionable benefits. When done correctly, Teva Pharmaceutical's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Teva Pharmaceutical.

Teva Pharmaceutical After-Hype Price Prediction Density Analysis

As far as predicting the price of Teva Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Teva Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Teva Pharmaceutical, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Teva Pharmaceutical Estimiated After-Hype Price Volatility

In the context of predicting Teva Pharmaceutical's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Teva Pharmaceutical's historical news coverage. Teva Pharmaceutical's after-hype downside and upside margins for the prediction period are 13.66 and 21.94, respectively. We have considered Teva Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
17.80
17.80
After-hype Price
21.94
Upside
Teva Pharmaceutical is somewhat reliable at this time. Analysis and calculation of next after-hype price of Teva Pharmaceutical is based on 3 months time horizon.

Teva Pharmaceutical Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Teva Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Teva Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Teva Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.38 
4.14
 0.00  
  0.13 
0 Events / Month
7 Events / Month
Within a week
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
17.80
17.80
0.00 
0.00  
Notes

Teva Pharmaceutical Hype Timeline

Teva Pharmaceutical is at this time traded for 17.80. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.13. Teva is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.38%. %. The volatility of related hype on Teva Pharmaceutical is about 1217.65%, with the expected price after the next announcement by competition of 17.67. The company has price-to-book ratio of 1.1. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Teva Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.8. The entity recorded a loss per share of 0.56. The firm last dividend was issued on the 28th of November 2017. Teva Pharmaceutical had 2:1 split on the 11th of December 2002. Assuming the 90 days horizon the next forecasted press release will be within a week.
Check out Teva Pharmaceutical Basic Forecasting Models to cross-verify your projections.

Teva Pharmaceutical Related Hype Analysis

Having access to credible news sources related to Teva Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Teva Pharmaceutical's future price movements. Getting to know how Teva Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Teva Pharmaceutical may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
ANIPANI Pharmaceuticals(1.27)11 per month 0.00 (0.06) 4.20 (3.95) 16.90 
ALKSAlkermes Plc(1.40)9 per month 1.71  0.08  4.14 (3.43) 10.99 
RDYDr Reddys Laboratories(0.18)9 per month 1.47 (0.04) 1.54 (2.45) 5.52 
COLLCollegium Pharmaceutical(0.25)9 per month 1.99  0.12  3.75 (3.30) 17.20 
PCRXPacira BioSciences, 0.36 10 per month 0.00 (0.03) 7.06 (4.48) 54.90 
VTRSViatris(0.42)11 per month 1.39  0.04  3.40 (2.64) 10.87 
CTLTCatalent(0.10)10 per month 0.00 (0.02) 0.74 (0.56) 2.57 
BHCBausch Health Companies(0.08)10 per month 4.85  0.05  3.80 (3.15) 26.39 
MNKMallinckrodt Plc(0.04)2 per month 13.99  0.03  12.50 (30.95) 504.19 
TLRYTilray Inc(0.02)11 per month 2.87 (0.03) 4.94 (5.29) 16.83 

Teva Pharmaceutical Additional Predictive Modules

Most predictive techniques to examine Teva price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Teva using various technical indicators. When you analyze Teva charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Teva Pharmaceutical Predictive Indicators

The successful prediction of Teva Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Teva Pharmaceutical Industries, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Teva Pharmaceutical based on analysis of Teva Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Teva Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Teva Pharmaceutical's related companies.

Story Coverage note for Teva Pharmaceutical

The number of cover stories for Teva Pharmaceutical depends on current market conditions and Teva Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Teva Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Teva Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Teva Pharmaceutical Short Properties

Teva Pharmaceutical's future price predictability will typically decrease when Teva Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Teva Pharmaceutical Industries often depends not only on the future outlook of the potential Teva Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Teva Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.1 B
Cash And Short Term Investments2.8 B

Complementary Tools for Teva Pink Sheet analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital